CJC-1295 & Ipamorelin Blend (10mg) – Research Peptide Compound in the United States

Core Peptide USA supplies high-quality peptide compounds intended strictly for laboratory and research purposes. Among our advanced peptide offerings, the CJC-1295 & Ipamorelin Blend (10mg) is widely studied in growth hormone–related research models due to the complementary pharmacokinetic profiles of its components.

Researchers across the United States rely on Core Peptide for transparency, consistency, and reliable sourcing. Each CJC-1295 & Ipamorelin Blend (10mg) vial is prepared with a focus on purity and documentation to support repeatable, non-clinical research.

👉 Learn more about our standards on the Quality Assurance page.

CJC-1295 & Ipamorelin Peptide Blend Overview

CJC-1295 and Ipamorelin are both classified by researchers as growth hormone secretagogues. Ipamorelin is a synthetic pentapeptide, while CJC-1295 is a 29–amino-acid peptide analog of growth hormone-releasing hormone (GHRH). Although distinct in structure, both peptides are frequently examined for their potential to stimulate endogenous growth hormone release via different but complementary mechanisms.

Researchers often note that CJC-1295 & Ipamorelin Blend (10mg) differs from single-peptide formats because of the contrasting half-life and receptor interaction profiles of its components. While Ipamorelin is characterized by a relatively short duration of action, CJC-1295 has been observed to exhibit prolonged plasma presence, making the blend a subject of interest in time-dependent signaling studies.

For general scientific background, see:

• NCBI – PubMed

• NIH – Growth Hormone Research

(External links provided for educational reference only.)

Mechanistic Insights from Research

CJC-1295

CJC-1295 is a tetrasubstituted analog of GHRH 1-29, the shortest biologically active segment of native GHRH. Researchers have identified substitutions at amino acid positions 2, 8, 15, and 27, which may increase resistance to enzymatic degradation. These modifications appear to enhance binding stability and extend apparent half-life compared to endogenous GHRH.

Some variants of CJC-1295 have been studied for their ability to associate with plasma proteins such as albumin, potentially prolonging circulation time. This extended pharmacokinetic profile has led researchers to explore CJC-1295 in studies involving sustained growth hormone pulsatility and insulin-like growth factor-1 (IGF-1) dynamics.

Ipamorelin

Ipamorelin (also known as NNC 26-0161) is a selective growth hormone secretagogue that interacts primarily with the GHS-R1a receptor, commonly referred to as the ghrelin receptor. Unlike some other GHS compounds, Ipamorelin has been reported in studies to show selectivity toward growth hormone release without significantly increasing other anterior pituitary hormones such as prolactin.

The peptide’s relatively short half-life—often cited around two hours—makes it useful in research models focusing on rapid receptor activation and short-term signaling events.

Combined Research Interest of CJC-1295 & Ipamorelin Blend (10mg)

When studied together, CJC-1295 & Ipamorelin Blend (10mg) is often described as exhibiting a complementary pattern of activity. Research observations suggest Ipamorelin may exert earlier receptor-mediated effects, while CJC-1295 may contribute to more prolonged signaling support. This temporal contrast is one reason the blend is frequently examined in endocrine and metabolic research models.

Scientific literature has explored the combined effects on:

• Growth hormone pulsatility

• IGF-1 modulation

• Somatotroph cell signaling

• Nitrogen balance in experimental settings

One area of interest involves nitrogen metabolism, where Ipamorelin has been examined for its potential impact on urea cycle markers and nitrogen equilibrium in controlled laboratory models. Meanwhile, CJC-1295 has been studied for its interaction with intracellular signaling cascades involving cAMP, G-proteins, and transcriptional regulation within somatotroph cells.

Chemical Makeup

Molecular Formula

• CJC-1295: C₁₅₂H₂₅₂N₄₄O₄₂

• Ipamorelin: C₃₈H₄₉N₉O₅

Molecular Weight

• CJC-1295: 3367.9 g/mol

• Ipamorelin: 711.8 g/mol

Other Known Names

• CJC-1295: Mod GRF 1-29, CJC-1295 NO DAC

• Ipamorelin: NNC 26-0161

Quality Standards at Core Peptide USA

Each CJC-1295 & Ipamorelin Blend (10mg) product from Core Peptide USA is manufactured and handled under strict protocols. Our commitment includes:

• High-purity raw materials

• Batch identification and consistency

• Third-party analytical verification

Researchers can explore additional compounds in our Research Peptides Collection.

U.S. Shipping & Research Compliance

Core Peptide USA ships CJC-1295 & Ipamorelin Blend (10mg) from within the United States, ensuring fast delivery and reliable tracking for domestic research institutions. All products are clearly labeled for research and laboratory use only and are not intended for human or veterinary use.

Please review our Terms and Conditions and Research Disclaimer before ordering.

Order CJC-1295 & Ipamorelin Blend (10mg) from Core Peptide USA

For researchers seeking a dependable source of CJC-1295 & Ipamorelin Blend (10mg) in the United States, Core Peptide USA offers quality, transparency, and responsive customer support. Our dedication to responsible peptide research makes us a trusted partner for laboratories nationwide.